Ewing’s U: Liquid Biopsy ctDNA detection in Ewing sarcoma

Ewing's U
Written By Alana Arens

Dr. Brian Crompton (at Dana Farber Cancer Institute) discusses the ongoing research behind liquid biopsy detection of Ewing sarcoma cells and ongoing efforts to leverage this technology to risk stratify patients at diagnosis, with the ultimate aim of changing the trajectory of cancer treatment on individual basis.

Alana Arens
Previous

Funding Philosophy: Valley of Death
Next

Ewing's U: NK Cell Therapy for Ewing sarcoma